Document:

Exhibit 4.21
​
(Summary Translation)
​
Facility Agreement with China Guangfa Bank, Urumqi Branch
​
	

	

	Date of the Agreement
	November 13, 2020

	 
	 

	Creditor (Party A)
	China Guangfa Bank, Urumqi Branch  

	 
	 

	Borrower (Party B)
	Xinjiang Daqo New Energy Co., Ltd.  

	 
	 

	Amount of revolving credit facility
	Up to RMB600 million (including up to RMB200 million of unsecured loans)  

	 
	 

	Form of loans
	Working capital loans, bank’s acceptance bill, discount on commercial bills, letter of credit

	 
	 

	Term of credit facility
	from November 13, 2020 to October 22, 2021  

	 
	 

	Use of loan proceeds
	Business operations

	 
	 

	Interest rate
	Loan Prime Rate

	 
	 

	Penalty rate
	In the event of failure to repay the loan in accordance with the Agreement, the penalty rate shall be 50% over the interest rate.
​
In the event of misappropriation of the loan proceeds under the Agreement, the penalty rate shall be 100% over the interest rate  

	 
	 

	Repayment of interest
	Interest shall be paid quarterly on the 21st of the last month of a quarter  

	 
	 

	Repayment of principal
	Principal shall be deposited in the specific repayment account three days prior to the maturity date and repaid in full by the maturity date  

	 
	 

	Security  
	Cash deposit

​
​

​
	

	​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​

	Party B’s Undertakings
	Party B undertakes the following:
​
(1) Party B shall provide its financial statements (including but not limited to annual reports, quarterly reports and monthly reports) and other relevant materials to Party A on a regular basis;
​
(2) Party B shall accept and cooperate with the inspection and supervision of Party A over its use of the loans and the related production operations and financial activities;
​
(3) Party B shall repay the loans in accordance with the agreement and cooperate with the management and inspection of Party A over its various accounts. Party B shall provide written explanations to Party A within two working days, if Party A notices any abnormal cash flow changes and requires Party B to provide explanation;
​
(4) When Party B submits its drawdown applications, Party B shall provide accurate documents to Party A in a timely manner. Otherwise, Party B shall be liable for any losses caused by its failure to submit the correct documents timely;
​
(5) Party B shall obtain Party A’s consent, if any of the following events occurs which may affect the financial condition and ability of performance of Party B, including but not limited to Party B’s conducting of division, merger, joint operation, equity and cooperative joint ventures, contracting, reorganization, restructuring, listing of shares, reduction of registered capital, transfer of material assets or equity interests, investment, assumption of material debt, or debt or equity financing;
​
(6) Party B shall report to Party A timely, if any of the following events occurs which may affect the financial conditions and ability of performance of Party B, including but not limited to closure, suspension, dissolution, cancellation, or bankruptcy, material litigation or arbitration, senior management’s involvement in criminal cases, deterioration of financial condition or business operations, or default under other agreements;
​
(7) Party B shall ensure its operations comply with regulations in relation to, among others, industrial policy, financial and tax policy, market entry requirement, environmental protection assessment, energy conservation, energy and pollution control, resource utilization, land and city planning and labor security. If Party B violates the abovementioned regulations, Party A is entitled to, among others, cease to extend the loan, declare all accrued loans immediately due and payable, dispose of the pledged assets immediately and require Party B to buy additional liability insurance relating to energy conservation and pollution;
​
(8) Party A’s debt shall be senior to Party B’s loans from Party B’s shareholders and has the same seniority as other comparable indebtedness of Party B;
​
(9) Party B shall not declare or pay dividends in the relevant financial years in event that (i) its after-tax profit is nil or negative or insufficient to make up previous year’s cumulative losses; (ii) its pre-tax profit has not been used to repay the principal and interest by the maturity dateor (iii) its pre-tax profit is insufficient to repay the principal and interests for the next installment;
​
(10) Party B shall not dispose of its assets by means which will affect its ability to repay the debt and Party B shall not guarantee the debt that exceeds or in aggregate exceeds the limits stipulated in its articles of association;
​
(11) Party B shall repay the principal and interests timely and pay relevant expenses incurred due to the execution and performance and disputes under the agreement including but not limited to the attorney fee and other expenses Party A incurred for the debt collection including the litigation expenses, enforcement expenses and attorney fees; and
​
(12) Enhance its environment and social risk management.  

​
​

​
	

	​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​

	Breach
	Any of the following constitutes a default under this Agreement:
​
(1) Party B fails to perform its repayment obligations to Party A in accordance with the Agreement;
​
(2) Party B fails to use the loans proceeds in accordance with this Agreement;
​
(3) Party B fails to repay the loans in accordance with the Agreement;
​
(4) Any of the representations made by Party B is not true or Party B breaches any of the undertakings made by it;
​
(5) Any event stipulated in the Agreement that occurs and, in the opinion of Party A, will adversely affect Party B’s financial condition and ability to repay the loans, and Party B fails to provide a guarantor;
​
(6) Party B breaches, or a cross-default occurs under, any other agreement with Party A or any other branches of China Guangfa Bank Co., Ltd;
​
(7) Party B fails to provide written explanations regarding abnormal changes of cash flows in relevant accounts under this Agreement within the time agreed with Party A;
​
(8) Party B fails to provide accurate documents and materials relating to the loans and loan disbursement;
​
(9) Party B terminates its business or suffers from dissolution, cancellation or bankruptcy;
​
(10) Party B otherwise violates this Agreement;

​
​

​
		If any of the above events occurs, Party A is entitled to take any or all of the following measures:
(1) Change the loan disbursement methods;
​
(2) Require Party B to rectify its violations within a specified period of time;
​
(3) Reduce, suspend or terminate the credit facility in whole or in part;
​
(4) Suspend or terminate the drawdowns pursuant to this Agreement or other agreements entered into between Party A and Party B in whole or in part; suspend or terminate the disbursement of loans or trade financing in whole or in part;
​
(5) Declare the principal, interest and other amounts immediately due and payable;
​
(6) Terminate or rescind the Agreement in whole or in part or rescind other agreements entered between Party A and Party B;
​
(7) Require Party B to compensate Party A for the losses incurred due to Party B’s violation of the Agreement;
​
(8) Deduct the principal from the account of Party B opened with Party A to repay all or part of the debt owed to Party A;
​
(9) Exercise rights over the collateral;
​
(10) Take stricter payment management measures or enhanced monitoring of Party B and its related parties, or add Party B into the blacklist and submit to the regulatory authorities and credit investigation authorities; or
​
(11) Take any other measures considered necessary or feasible by Party A.  

​Exhibit 4.22
​
(Summary Translation)
​
	Working Capital Loan Agreement with Xinjiang Bank

	Date of the Agreement
	April 13, 2020

	Borrower (Party A)
	Xinjiang Daqo New Energy Co., Ltd.

	Lender (Party B)
	Xinjiang Bank

	Use of loan
	Business operation

	Amount
	RMB80 million

	Term of loan
	1 year, from April 14, 2020 to April 13, 2021

	Interest rate
	Fixed rate at 5.655%, which will not change during the term of loan

	Penalty rate
	In the event of misappropriation of the loan proceeds under the Agreement, the penalty rate shall be 100% over the interest rate.
In the event of repayment default, the penalty rate shall be 50% over the interest rate.
​
A compound interest will be imposed on any overdue interest.

	Interest settlement day
	Interest shall be paid monthly at the last 21st day of each month.

	Repayment of principal
	Principal shall be repaid in full on April 13, 2021.

	Guarantee and Security
	Guarantee provided by Daqo Group Co., Ltd.
​
The apartment buildings provided by Xinjiang Daqo Investment Co., Ltd. as collateral

​
​

​
	Party A’s covenants
	Party A shall:
​
(1) Notify Party B in at least 30 days advance and obtain a written consent from Party B in respect of investment, substantially increase of debt financing, merger, spinoff, decrease of share capital, share transfer, asset transfer, suspension of business, dissolution, bankruptcy and other actions which will affect the interest of Party B, and shall fulfill its repayment obligations;
​
(2) Within the term of loan, without Party B's written consent, Party A shall not assume the obligation to pay any debts of any third party, provide any guarantee or set any mortgage or pledge over Party A's asset or interest which would affect Party A's ability of repayment of the loan;
​
(3) Other than specified above, notify Party B in written immediately in respect of any matter which may jeopardize Party A's normal operation or cause material adverse impact to its ability to its performance of this Agreement.

​Exhibit 4.1

 

AMENDMENT AGREEMENT

 

This Amendment Agreement (this
“Agreement”) is made and entered into as of April 16, 2021 by and among BOQI INTERNATIONAL MEDICAL INC., a company
organized under the laws of the state of Delaware, the U.S.A. (“Parent”), BIMAI PHARMACEUTICAL (CHONGQING) CO., LTD., a company
organized under the laws of the PRC (“Buyer”), WUZHOU QIANGSHENG HOSPITAL CO., LTD., a company organized under the laws of
the PRC ( “Qiangsheng”), SUZHOU EURASIA HOSPITAL CO., LTD., a company organized under the laws of the PRC (“Eurasia”),
YUNAN YUXI MINKANG HOSPITAL CO., LTD., a company organized under the laws of the PRC (“Minkang”), Mr. JIANGJIN SHEN, an individual
residing in the PRC (“Jiangjin”), and Mr. ZHIWEI SHEN, an individual residing in the PRC (“Zhiwei”). Jiangjin
and Zhiwei are herein collectively as the “Sellers.” Each of the parties named above may be referred to herein as a “Party”
and collectively as the “Parties.”

 

RECITALS

 

WHEREAS, Parties are
parties to that certain Stock Purchase Agreement dated as of April 9, 2021 (the “Original Agreement”), where Buyer
agreed to purchase all the issued and outstanding shares of capital stock in Qiangsheng, Eurasia and Minkang Shares from Sellers;

 

WHEREAS, the Parties
desire to amend certain terms and conditions of the Original Agreement;

 

WHEREAS, pursuant to
Section 13.7 of the Original Agreement, amendments to the Original Agreement shall be in writing and shall require the written
consent of all parties involved; and

 

WHEREAS, the undersigned constitute all
parties to the Original Agreement.

 

NOW, THEREFORE, in
consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

 

1. Defined
Terms. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms in the Original Agreement.

 

    1

     

    

 

2. Amendment.
The Parties hereby agree to amend the Original Agreement (as amended by this Agreement, the “Amended Agreement”) as
follows:

 

		(1)	Section 2.6 (d) is hereby amended and restated in its entirety as follows:

 

“(d) Notwithstanding anything
to the contrary contained herein, Buyer may elect, at its sole discretion, to have the Second Payment and/or the Third Payment paid
in the form of the Parent Shares, by delivering a written notice about Buyer’s exercise of this option (the “Option
Exercise Notice”), to Sellers simultaneously with the delivery of the Final 2021 Profit Statement, or the Final 2022
Profit Statement, as the case may be. The number of the Parent Shares (the “Earnout Parent Shares”) to be issued
as payments under this Section 2.6(d) shall be the result of the amount of the Second Payment or the Third Payment, as the
case may be, divided by $3.00. Notwithstanding anything to the contrary further, if (A) the Closing Stock Payment and any of the
Earnout Parent Shares issuable, calculated collectively, will have voting power equal to or in excess of 20% of the total voting
power outstanding as of the date hereof, or (B) the aggregate number of the Closing Stock Payment and any of the Earnout Parent
Shares issuable will be equal to or in excess of 20% of the total number of Parent Shares outstanding as of the date hereof, the
issuance of the Earnout Parent Shares must be approved by Parent’s shareholders (the “Parent’s Shareholders
Approval”) pursuant to Nasdaq Rule 5635. In the event the Parent’s Shareholders Approval becomes necessary pursuant
to the foregoing sentence, no Earnout Parent Shares shall be issued to Sellers unless and until the Parent’s Shareholders
Approval has been obtained, and the Second Payment Date or the Third Payment Date, as the case may be, shall be extended until the
fifteenth (15th) date after the Parent’s Shareholders Approval has been received. If the Parent’s Shareholders Approval
has not been received within one (1) year after Buyer delivers the Option Exercise Note, the Second Payment or the Third Payment, as
the case may be, shall be paid in Cash to Sellers immediately.”

 

		(2)	Reference to and Effect on the Original Agreement. On or after the date hereof, each reference in the Original Agreement to
“this Agreement,” “hereunder,” “herein” or words of like import shall mean and be a reference to the
Original Agreement as amended hereby. No reference to this Agreement need be made in any instrument or document at any time referring
to the Original Agreement, a reference to the Original Agreement in any of such to be deemed a reference to the Amended Agreement.

 

		(3)	No Other Amendments. Except as set forth herein, the Original Agreement shall remain in full force and effect in accordance
with its terms, which such terms are hereby ratified and confirmed and remain in full force and effect.

 

3. Counterparts.
This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which together shall constitute
one instrument.

 

4. Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing
or interpreting this Agreement.

 

5. Governing
Law. This Agreement and all acts and transactions pursuant hereto and the rights of obligations of the parties hereto shall be governed,
construed and interpreted in accordance with the laws of the State of New York without regard to its choice of laws principles. Any unresolved
controversy or claim arising out of this Agreement will be governed in accordance with the provisions of the Original Agreement.

 

6. Representation
by Counsel. Each of the parties hereto has been represented or has had the opportunity to be represented by legal counsel of their
own choice.

 

(Signature Pages Follow)

 

    2

     

    

 

IN WITNESS WHEREOF, the parties
have executed this Agreement as of the date first above written.

 

	BUYER:	 
	 	 	 
	BIMAI PHARMACEUTICAL (CHONGQING) CO., LTD.
	 	 
	By: 	/s/ Xiaoping Wang          	 
	Name: 	Xiaoping Wang   
	Title:	CEO

 

	PARENT:	 
	 	 	 
	BOQI INTERNATIONAL MEDICAL INC.	 
	 	 	 
	By:	/s/ Tiewei Song                      	 
	Name:	Tiewei Song                   	 
	Title:	CEO	 

 

	SELLERS: 
	 
	JIANGJIN SHEN
	 	 	 
	By:	/s/ Jiangjin Shen	 
	Name:  	Jiangjin Shen	 
	Address: No. 214-1, Xihuang Village, Donghai County, Chengxiang District, Putian City,
	Fujian Province, PRC	 

 

	ZHIWEI SHEN	 
	 	 	 
	By:	/s/ Zhiwei Shen	 
	Name: 	Zhiwei Shen	 
	Address: No. 214, Xihuang Village, Donghai County, Chengxiang District, Putian City,
	Fujian Province, PRC	 

 

	Acquired COMPANIES:	 
	 	 	 
	WUZHOU QIANGSHENG HOSPITAL CO., LTD.	 
	 	 	 
	By:	/s/ Zhiwei Shen	 
	Name: 	Zhiwei Shen	 
	Title:	Chairman of the Board	 

 

	SUZHOU EURASIA HOSPITAL CO., LTD.	 
	 	 	 
	By:	/s/ Jiangjin Shen	 
	Name: 	Jiangjin Shen	 
	Title:	Chairman of the Board	 

 

	YUNAN YUXI MINKANG HOSPITAL CO., LTD.	 
	 	 	 
	By: 	/s/ Jiangjin Shen 	 
	Name: 	Jiangjin Shen	 
	Title: 	Chairman of the Board	 

 

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]